These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29335321)

  • 21. The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients.
    Thomson PC; Morris ST; Mactier RA
    Clin Nephrol; 2011 Mar; 75(3):212-7. PubMed ID: 21329631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complications From Tunneled Hemodialysis Catheters: A Canadian Observational Cohort Study.
    Poinen K; Quinn RR; Clarke A; Ravani P; Hiremath S; Miller LM; Blake PG; Oliver MJ
    Am J Kidney Dis; 2019 Apr; 73(4):467-475. PubMed ID: 30642607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
    Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
    Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of tunneled cuffed hemodialysis catheter-related dysfunction and bacteremia by a neutral-valve closed-system connector: a single-center randomized controlled trial.
    Bonkain F; Racapé J; Goncalvez I; Moerman M; Denis O; Gammar N; Gastaldello K; Nortier JL
    Am J Kidney Dis; 2013 Mar; 61(3):459-65. PubMed ID: 23228946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial.
    Kanaa M; Wright MJ; Akbani H; Laboi P; Bhandari S; Sandoe JA
    Am J Kidney Dis; 2015 Dec; 66(6):1015-23. PubMed ID: 26141306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of urokinase lock to treat thrombotic dysfunction of tunneled hemodialysis catheters: A retrospective cohort study.
    Van Hulle F; Bonkain F; De Clerck D; Aerden D; Vanwijn I; Tielemans C; Wissing KM
    J Vasc Access; 2019 Jan; 20(1):60-69. PubMed ID: 29893163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting tissue plasminogen activator use and success in in-center hemodialysis patients.
    Kosa SD; Ye C; Thabane L; Gafni A; Lok CE
    J Vasc Access; 2018 Mar; 19(2):146-152. PubMed ID: 28983900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective observational study of the change in systemic ionised calcium following 4% citrate locking of venous haemodialysis catheters in intensive care patients.
    Shewdin S; Bong YC; Okano S; Chatfield MD; Walsham J
    Anaesth Intensive Care; 2018 Jul; 46(4):381-385. PubMed ID: 29966111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
    Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
    Yon CK; Low CL
    Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: systematic review and meta-analysis of randomized, controlled trials.
    Wang AY; Ivany JN; Perkovic V; Gallagher MP; Jardine MJ
    Nephrol Dial Transplant; 2013 Nov; 28(11):2875-88. PubMed ID: 24169613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients.
    Zwiech R; Adelt M; Chrul S
    Am J Ther; 2016; 23(2):e363-8. PubMed ID: 23665885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporary hemodialysis catheters as a long-term vascular access in chronic hemodialysis patients.
    Ponikvar R; Buturović-Ponikvar J
    Ther Apher Dial; 2005 Jun; 9(3):250-3. PubMed ID: 15967000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS).
    Macrae JM; Dojcinovic I; Djurdjev O; Jung B; Shalansky S; Levin A; Kiaii M
    Clin J Am Soc Nephrol; 2008 Mar; 3(2):369-74. PubMed ID: 18308996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
    Solomon LR; Cheesbrough JS; Ebah L; Al-Sayed T; Heap M; Millband N; Waterhouse D; Mitra S; Curry A; Saxena R; Bhat R; Schulz M; Diggle P
    Am J Kidney Dis; 2010 Jun; 55(6):1060-8. PubMed ID: 20207458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical application of 4% sodium citrate and heparin in the locking of central venous catheters (excluding dialysis catheters) in intensive care unit patients: A pragmatic randomized controlled trial.
    Deng Y; Xing J; Tan Z; Ai X; Li Y; Zhang L
    PLoS One; 2023; 18(7):e0288117. PubMed ID: 37399185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low dose heparin lock (1000 U/mL) maintains tunnelled hemodialysis catheter patency when compared with high dose heparin (5000 U/mL): A randomised controlled trial.
    Chu G; Fogarty GM; Avis LF; Bergin S; McElduff P; Gillies AH; Choi P
    Hemodial Int; 2016 Jul; 20(3):385-91. PubMed ID: 26833752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.
    Weijmer MC; van den Dorpel MA; Van de Ven PJ; ter Wee PM; van Geelen JA; Groeneveld JO; van Jaarsveld BC; Koopmans MG; le Poole CY; Schrander-Van der Meer AM; Siegert CE; Stas KJ;
    J Am Soc Nephrol; 2005 Sep; 16(9):2769-77. PubMed ID: 16033861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of hemodialysis catheter-associated fibrin sheaths by rt-PA infusion: critical analysis of 124 procedures.
    Savader SJ; Ehrman KO; Porter DJ; Haikal LC; Oteham AC
    J Vasc Interv Radiol; 2001 Jun; 12(6):711-5. PubMed ID: 11389222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incidence and costs of bacteremia due to lack of gentamicin lock solutions for dialysis catheters.
    Goh TL; Wei J; Semple D; Collins J
    Nephrology (Carlton); 2017 Jun; 22(6):485-489. PubMed ID: 28429519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.